Back to Markets
CSCastle Biosciences Inc

Castle Biosciences Inc

CSTLNASDAQ NMS - GLOBAL MARKET
Health CareHealth Care

$21.08

-1.030000 (-4.66%)

As of 05/29/26 EDT · USD

Compare
Low: $14.59Current: $21.08High: $44.28

Key Statistics

Open

$21.99

Day High

$22.14

Day Low

$20.99

Prev. Close

$22.11

VolumeShares traded today.

332.18K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$639.36M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-49.08

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$44.28

52W LowLowest price over the past 52 weeks.

$14.59

50D MAAverage closing price over the last 50 trading days.

$23.08

200D MAAverage closing price over the last 200 trading days.

$28.74

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+2.6%

1M

-13.0%

6M

-47.2%

YTD

-45.3%

1Y

+32.0%

About

DecisionDx-UM is a prognostic test that accurately determines the metastatic risk associated with ocular melanoma tumors of the eye. Ocular melanoma is a term commonly used to describe tumors of the uveal tract such as uveal melanoma, choroidal melanoma, ciliary body melanoma, and iris melanoma. The DecisionDx-UM test was clinically validated on these tumors of the uveal tract. DecisionDx-UM assesses the gene expression profile (GEP) of a subset of genes which are differentially expressed in primary tumor cells compared to cells that have undergone transformation to a metastatic phenotype.

castlebiosciences.com/

Company Facts

SectorHealth Care
IndustryHealth Care
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CSTL

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.